Substantially Improving the Cure Rate of High-risk BRCA1-like Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: ddAC-CP-Olaparib|DRUG: ddAC-mini CTC
Sponsor: The Netherlands Cancer Institute